We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
-8.52%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$148M
AUM Growth
-$20.7M
Cap. Flow
-$4.64M
Cap. Flow %
-3.14%
Top 10 Hldgs %
59.53%
Holding
55
New
–
Increased
21
Reduced
27
Closed
6

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$80.6K
2
MRK icon
Merck
MRK
+$74.6K
3
JNJ icon
Johnson & Johnson
JNJ
+$61.4K
4
BA icon
Boeing
BA
+$57.8K
5
ABT icon
Abbott
ABT
+$56.8K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$423K
2
AAPL icon
Apple
AAPL
+$404K
3
ET icon
Energy Transfer Partners
ET
+$375K
4
ILMN icon
Illumina
ILMN
+$362K
5
CELG
Celgene Corp
CELG
+$300K

Sector Composition

Rank Sector Weight
1 Healthcare 37.25%
2 Technology 24.31%
3 Consumer Discretionary 20.85%
4 Communication Services 10.06%
5 Industrials 2.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
26
Bristol-Myers Squibb
BMY
$130B
$779K 0.53%
13,160
+1,270
+11% +$80.6K
HD icon
27
Home Depot
HD
$344B
$753K 0.51%
6,522
-40
-0.6% -$4.63K
BA icon
28
Boeing
BA
$175B
$675K 0.46%
5,152
+417
+9% +$57.8K
TTSH
29
DELISTED
Tile Shop Holdings
TTSH
$660K 0.45%
55,071
-3,095
-5% -$41K
JNJ icon
30
Johnson & Johnson
JNJ
$648B
$562K 0.38%
6,022
+635
+12% +$61.4K
ABT icon
31
Abbott
ABT
$187B
$549K 0.37%
13,647
+1,205
+10% +$56.8K
WBA
32
DELISTED
Walgreens Boots Alliance
WBA
$518K 0.35%
6,233
+435
+8% +$39.3K
LLY icon
33
Eli Lilly
LLY
$1.09T
$473K 0.32%
561
-5,015
-90% -$423K
NSC icon
34
Norfolk Southern
NSC
$77.2B
$437K 0.3%
5,725
+60
+1% +$4.88K
PFE icon
35
Pfizer
PFE
$143B
$428K 0.29%
14,347
+443
+3% +$14.2K
T icon
36
AT&T
T
$169B
$399K 0.27%
16,227
+25
+0.2% +$637
NEE icon
37
NextEra Energy
NEE
$188B
$383K 0.26%
15,724
+260
+2% +$6.61K
PAYX icon
38
Paychex
PAYX
$42.4B
$363K 0.25%
7,621
+200
+3% +$9.33K
MRK icon
39
Merck
MRK
$325B
$338K 0.23%
7,182
+1,404
+24% +$74.6K
JPM icon
40
JPMorgan Chase
JPM
$946B
$307K 0.21%
5,039
+65
+1% +$4.26K
TROW icon
41
T. Rowe Price
TROW
$25.9B
$289K 0.2%
4,157
+50
+1% +$3.7K
SLB icon
42
SLB Ltd
SLB
$74.9B
$280K 0.19%
4,054
+125
+3% +$9.9K
ET icon
43
Energy Transfer Partners
ET
$68.6B
$261K 0.18%
12,566
-13,286
-51% -$375K
VZ icon
44
Verizon
VZ
$202B
$260K 0.18%
5,985
-460
-7% -$21.2K
COST icon
45
Costco
COST
$432B
$254K 0.17%
1,760
+75
+4% +$10.7K
NUE icon
46
Nucor
NUE
$60.2B
$248K 0.17%
6,614
– –
DUK icon
47
Duke Energy
DUK
$102B
$233K 0.16%
3,232
+205
+7% +$14.8K
TGT icon
48
Target
TGT
$65.5B
$231K 0.16%
2,940
+130
+5% +$10.4K
CVX icon
49
Chevron
CVX
$373B
$202K 0.14%
2,555
+145
+6% +$12.2K
CAT icon
50
Caterpillar
CAT
$385B
– –
-2,382
Closed -$202K
1
2
3

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return
VM
Venator Management Pittsburgh, Pennsylvania $416M AUM 16.01% 1-Year Est. Return

Bender Robert & Associates's Q3 2015 Portfolio in Review

As of Q3 2015, Bender Robert & Associates held 55 positions worth $148M, down 12% from $168M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Bender Robert & Associates withdrew a net $4.64M in Q3 2015, closing 6 positions and reducing 27 holdings. Its most notable exit was International Paper, an estimated $252K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 39% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Bender Robert & Associates added an estimated $80.6K to Bristol-Myers Squibb.

  • Bender Robert & Associates added most to Bristol-Myers Squibb in Q3 2015, an estimated $80.6K increase.
  • Bender Robert & Associates's biggest Q3 2015 reduction was Eli Lilly, cutting an estimated $423K.
  • Bender Robert & Associates fully exited International Paper in Q3 2015, selling an estimated $252K.
  • Bender Robert & Associates's ten largest holdings make up 60% of its $148M portfolio in Q3 2015.
  • Bender Robert & Associates opened 0 new positions and closed 6 in Q3 2015.
  • Bender Robert & Associates's portfolio value fell 12% quarter-over-quarter to $148M.

Based on Bender Robert & Associates's 13F filing for Q3 2015, filed 29 Oct 2015.